149 related articles for article (PubMed ID: 31876829)
1. Extracranial Metastases From Glioblastoma With Primitive Neuronal Components on FDG PET/CT.
Kay MD; Pariury HE; Perry A; Winegar BA; Kuo PH
Clin Nucl Med; 2020 Mar; 45(3):e162-e164. PubMed ID: 31876829
[TBL] [Abstract][Full Text] [Related]
2. Extracranial bone metastases from recurrent anaplastic astrocytoma on FDG PET/CT: A case report a care-compliant article.
Li ZG; Mu HY
Medicine (Baltimore); 2017 Jun; 96(23):e7123. PubMed ID: 28591062
[TBL] [Abstract][Full Text] [Related]
3. Detection of multiple extracranial metastases from glioblastoma multiforme by means of whole-body [18F]FDG-PET.
Mirzayan MJ; Samii M; Petrich T; Börner AR; Knapp WH; Samii A
Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):853. PubMed ID: 15776231
[No Abstract] [Full Text] [Related]
4. FDG PET/CT in Recurrent Glioblastoma Multiforme With Leptomeningeal and Diffuse Spinal Cord Metastasis.
Malik D
Clin Nucl Med; 2021 Feb; 46(2):138-139. PubMed ID: 33234937
[TBL] [Abstract][Full Text] [Related]
5. Brain metastases detectability of routine whole body (18)F-FDG PET and low dose CT scanning in 2502 asymptomatic patients with solid extracranial tumors.
Bochev P; Klisarova A; Kaprelyan A; Chaushev B; Dancheva Z
Hell J Nucl Med; 2012; 15(2):125-9. PubMed ID: 22741148
[TBL] [Abstract][Full Text] [Related]
6.
Jain TK; Basher RK; Sood A; Mittal BR; Prakash G; Bhatia A
J Nucl Med Technol; 2017 Jun; 45(2):114-115. PubMed ID: 28280127
[TBL] [Abstract][Full Text] [Related]
7. The impact of
Elmanzalawy A; Vali R; Chavhan GB; Gupta AA; Omarkhail Y; Amirabadi A; Shammas A
Pediatr Radiol; 2020 Feb; 50(2):252-260. PubMed ID: 31628508
[TBL] [Abstract][Full Text] [Related]
8. Whole-body
Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
[TBL] [Abstract][Full Text] [Related]
9. Identification of Distant Metastases From Recurrent Gliosarcoma Using Whole-Body 18F-FDG PET/CT.
Unterrainer M; Ruf V; Cyran CC; Brendel M; Thon N; Herms J; Schüller U; Tonn JC; Bartenstein P; Albert NL
Clin Nucl Med; 2019 Nov; 44(11):923-924. PubMed ID: 31584491
[TBL] [Abstract][Full Text] [Related]
10. Role of FDG-PET/MRI, FDG-PET/CT, and Dynamic Susceptibility Contrast Perfusion MRI in Differentiating Radiation Necrosis from Tumor Recurrence in Glioblastomas.
Hojjati M; Badve C; Garg V; Tatsuoka C; Rogers L; Sloan A; Faulhaber P; Ros PR; Wolansky LJ
J Neuroimaging; 2018 Jan; 28(1):118-125. PubMed ID: 28718993
[TBL] [Abstract][Full Text] [Related]
11. Common malignant brain tumors: can 18F-FDG PET/CT aid in differentiation?
Purandare NC; Puranik A; Shah S; Agrawal A; Gupta T; Moiyadi A; Shetty P; Shridhar E; Jalali R; Rangarajan V
Nucl Med Commun; 2017 Dec; 38(12):1109-1116. PubMed ID: 28922334
[TBL] [Abstract][Full Text] [Related]
12. Solitary vertebral metastatic glioblastoma in the absence of primary brain tumor relapse: a case report and literature review.
Li ZG; Zheng MY; Zhao Q; Liu K; Du JX; Zhang SW
BMC Med Imaging; 2020 Jul; 20(1):89. PubMed ID: 32736607
[TBL] [Abstract][Full Text] [Related]
13. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of glioma.
Shaw TB; Jeffree RL; Thomas P; Goodman S; Debowski M; Lwin Z; Chua B
J Med Imaging Radiat Oncol; 2019 Oct; 63(5):650-656. PubMed ID: 31368665
[TBL] [Abstract][Full Text] [Related]
15. Extracranial metastasis of pediatric glioblastoma: case report and literature review.
Huang WZ; Chen HC; Chang TK; You WC; Jan YJ; Chou YC
Childs Nerv Syst; 2024 Mar; 40(3):933-937. PubMed ID: 37982875
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
[TBL] [Abstract][Full Text] [Related]
17. Case of metastatic glioblastoma with primitive neuronal component to the lung.
Tamai S; Kinoshita M; Sabit H; Furuta T; Miyashita K; Yoshimura K; Homma T; Harada K; Nakada M
Neuropathology; 2019 Jun; 39(3):218-223. PubMed ID: 31025405
[TBL] [Abstract][Full Text] [Related]
18. (18)F-fluoromethylcholine (FCho), (18)F-fluoroethyltyrosine (FET), and (18)F-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: a PET study.
Bolcaen J; Descamps B; Deblaere K; Boterberg T; De Vos Pharm F; Kalala JP; Van den Broecke C; Decrock E; Leybaert L; Vanhove C; Goethals I
Nucl Med Biol; 2015 Jan; 42(1):38-45. PubMed ID: 25218024
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of
Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.
Machado Medeiros T; Altmayer S; Watte G; Zanon M; Basso Dias A; Henz Concatto N; Hoefel Paes J; Mattiello R; de Souza Santos F; Mohammed TL; Verma N; Hochhegger B
Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
